Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Other Working Capital Changes: 2019-2024

Historic Other Working Capital Changes for Compass Therapeutics (CMPX) over the last 6 years, with Dec 2024 value amounting to $4.9 million.

  • Compass Therapeutics' Other Working Capital Changes fell 154.33% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year decrease of 249.28%. This contributed to the annual value of $4.9 million for FY2024, which is 171.83% up from last year.
  • According to the latest figures from FY2024, Compass Therapeutics' Other Working Capital Changes is $4.9 million, which was up 171.83% from -$6.8 million recorded in FY2023.
  • In the past 5 years, Compass Therapeutics' Other Working Capital Changes ranged from a high of $5.6 million in FY2022 and a low of -$6.8 million during FY2023.
  • Over the past 3 years, Compass Therapeutics' median Other Working Capital Changes value was $4.9 million (recorded in 2024), while the average stood at $1.2 million.
  • As far as peak fluctuations go, Compass Therapeutics' Other Working Capital Changes surged by 603.68% in 2020, and later tumbled by 220.94% in 2023.
  • Over the past 5 years, Compass Therapeutics' Other Working Capital Changes (Yearly) stood at $2.2 million in 2020, then tumbled by 150.71% to -$1.1 million in 2021, then soared by 603.24% to $5.6 million in 2022, then tumbled by 220.94% to -$6.8 million in 2023, then spiked by 171.83% to $4.9 million in 2024.